These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 9713338)
1. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338 [TBL] [Abstract][Full Text] [Related]
2. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver. Lamb RF; Going JJ; Pickford I; Birnie GD Cancer Res; 1996 Feb; 56(4):916-20. PubMed ID: 8631033 [TBL] [Abstract][Full Text] [Related]
3. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients. Conzelmann M; Linnemann U; Berger MR Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598 [TBL] [Abstract][Full Text] [Related]
4. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer. Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689 [TBL] [Abstract][Full Text] [Related]
5. Association of K-ras mutations with liver metastases from colorectal carcinoma. Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200 [TBL] [Abstract][Full Text] [Related]
6. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence. Kato M; Ito Y; Kobayashi S; Isono K Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570 [TBL] [Abstract][Full Text] [Related]
7. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer. Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039 [TBL] [Abstract][Full Text] [Related]
8. Predominance of G to A codon 12 mutation K-ras gene in Dukes' B colorectal cancer. Zulhabri O; Rahman J; Ismail S; Isa MR; Wan Zurinah WN Singapore Med J; 2012 Jan; 53(1):26-31. PubMed ID: 22252179 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer. Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P Anticancer Res; 2000; 20(3A):1695-701. PubMed ID: 10928094 [TBL] [Abstract][Full Text] [Related]
10. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study. Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747 [TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of the presence of the mutation of the codons 12, 13 and 61 in K-ras oncogene in colorectal cancer]. Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P Orv Hetil; 1999 Jul; 140(30):1673-9. PubMed ID: 10461447 [TBL] [Abstract][Full Text] [Related]
12. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
13. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases. Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496 [TBL] [Abstract][Full Text] [Related]
14. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report. Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas. Ishii M; Sugai T; Habano W; Nakamura S J Gastroenterol; 2004 Jun; 39(6):544-9. PubMed ID: 15235871 [TBL] [Abstract][Full Text] [Related]
16. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Schimanski CC; Linnemann U; Berger MR Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292). Wadler S; Bajaj R; Neuberg D; Agarwal V; Haynes H; Benson AB Cancer J Sci Am; 1997; 3(5):284-8. PubMed ID: 9327152 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623 [TBL] [Abstract][Full Text] [Related]